Table 1

Characteristics of patients who died during treatment with GP IIb/IIIa inhibitors

	Eptifibatide	Tirofiban	Abciximab	Total
Deaths	103	143	207	450
Female (%)	38	51	45	47
Age (years)
Range	39– 90	30–97	23– 96	23–97
Median	70	72	68	70
Mean	70	71	67	69
Haemorrhage (%)	85	72	82	80
Myocardial infarction (%)	16	24	17	19
Thrombocytopenia (%)	6	18	14	13